JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Shigeki Morita
Munetaka Masuda
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanoue, Y.
Right arrow Articles by Yasui, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanoue, Y.
Right arrow Articles by Yasui, H.

J Thorac Cardiovasc Surg 1996;112:1017-1026
© 1996 Mosby, Inc.


CARDIAC AND PULMONARY REPLACEMENT

INHIBITION OF LIPID PEROXIDATION WITH THE LAZAROID U74500A ATTENUATES ISCHEMIA-REPERFUSION INJURY IN A CANINE ORTHOTOPIC HEART TRANSPLANTATION MODEL

Yoshihisa Tanoue, MD, Shigeki Morita, MD, Yoshie Ochiai, MD, Manabu Hisahara, MD, Munetaka Masuda, MD, Yoshito Kawachi, MD, Ryuji Tominaga, MD, Hisataka Yasui, MD

Supported in part by grant-in-aid for scientific research 07671479 from the Ministry of Education, Science, and Culture, Tokyo.

Received for publication Jan. 24, 1996 Revisions requested Feb. 29, 1996; revisions received March 21, 1996 Accepted for publication March 26, 1996. Address for reprints: Shigeki Morita, MD, Department of Cardiovascular Surgery, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-82, Japan.

Abstract

Background: The lazaroid U74500A is a 21-aminosteroid that inhibits lipid peroxidation and attenuates ischemia-reperfusion injury. We examined the effect of U74500A on heart preservation with the use of a clinically relevant canine orthotopic heart transplantation model. Methods and results: Six donor dogs (group L) were pretreated intravenously with U74500A (10 mg/kg), and the dogs without pretreatment served as a control (group C, n = 6). The donor heart was preserved in cold University of Wisconsin solution for 24 hours. The heart was then transplanted orthotopically. Myocardial biopsy was performed to measure the adenosine triphosphate level at the end of ischemia. Before reperfusion, recipients in group L received another dose of U74500A (10 mg/kg) intravenously. After 3 hours of reperfusion, left ventricular function was evaluated by left ventricular pressure-volume relations with the use of a Millar catheter and conductance catheter, thereby deriving the slope of the end-systolic pressure-volume relation, the slope of the stroke work–end-diastolic volume relation, and the slope of the maximum dP/dt–end-diastolic volume relation. At the same time, serum creatine kinase MB isoenzyme and lipid peroxide levels were measured. The slopes of the end-systolic pressure-volume relation, the stroke work–end-diastolic volume relation, and the maximum dP/dt–end-diastolic volume relation for group L were significantly higher than those for group C. The adenosine triphosphate levels for group L were significantly higher than those for group C. Serum creatine kinase MB isoenzyme and lipid peroxide levels for group L were significantly lower than those for group C. Conclusions: Inhibition of lipid peroxidation by the administration of U74500A was effective for 24-hour canine cardiac preservation. These results indicate that U74500A is a promising agent for heart allograft preservation. (J THORACCARDIOVASCSURG1996;112:1017-26)




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
N. Kajihara, S. Morita, Y. Tanoue, N. Boku, M. Eto, T. Nishida, and R. Tominaga
The UW solution has greater potential for longer preservation periods than the Celsior solution: comparative study for ventricular and coronary endothelial function after 24-h heart preservation.
Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 784 - 789.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. B. Ryan, M. Hicks, J. R. Cropper, S. R. Garlick, S. H. Kesteven, M. K. Wilson, P. S. Macdonald, and M. P. Feneley
The preload recruitable stroke work relationship as a measure of left ventricular contractile dysfunction in porcine cardiac allografts
Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 738 - 745.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Tanoue, A. Sese, Y. Ueno, K. Joh, and T. Hijii
Bidirectional Glenn Procedure Improves the Mechanical Efficiency of a Total Cavopulmonary Connection in High-Risk Fontan Candidates
Circulation, May 1, 2001; 103(17): 2176 - 2180.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Tanoue, S. Morita, Y. Ochiai, N. Haraguchi, R. Tominaga, Y. Kawachi, and H. Yasui
NITROGLYCERIN AS A NITRIC OXIDE DONOR ACCELERATES LIPID PEROXIDATION BUT PRESERVES VENTRICULAR FUNCTION IN A CANINE MODEL OF ORTHOTOPIC HEART TRANSPLANTATION
J. Thorac. Cardiovasc. Surg., September 1, 1999; 118(3): 547 - 556.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Nishida, S. Morita, M. Masuda, R. Tominaga, Y. Kawachi, and H. Yasui
Lazaroid U74500A is superior to U74006F in preserving rabbit heart for 24 hours
Ann. Thorac. Surg., November 1, 1998; 66(5): 1647 - 1652.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The American Association for Thoracic Surgery.